Kia Airbag Recall Impacts 500K Forte, Optima and Sedona Vehicles

Following reports of airbags failing to deploy, which may have resulted in at least four deaths, more than half a million Kia Optima, Forte and Sedona vehicles are being recalled, due to a risk that the airbag control units may short circuit. 

The Kia airbag recall was announced by the U.S. National Highway Traffic Safety Administration (NHTSA) on June 7, following an investigation into six reports of problems with Hyundai vehicles that feature the same airbag control unit, which has been linked to at least four deaths and six injuries.

About 507,000 Kia cars and minivans are impacted by this latest recall, which all feature an airbag control unit supplied by ZF-TRW, which is the same supplier of Hyundai airbag control units linked to recent problems with short-circuits that may cause the airbag to fail to deploy when needed to prevent serious injury or death.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

In March 2018, Hyundai recalled more than 600,000 vehicles, and it now appears that the same issues may impact Kia vehicles, raising questions why it took several months for this latest recall to be announced.

The NHTSA launched an investigation March 16 into Hyundai and Kia vehicles after the agency received six reports of incidents when the airbags. Kia indicates no injuries or deaths have occurred that were associated with the recalled airbags on the affected vehicles. However, the investigation remains open.

The Kia recall affects model year 2010-2013 Forte and Forte Koup vehicles, as well as 2011-2013 Optima, 2011-2012 Optima Hybrid, and 2011-2012 Kia Sedona vehicles.

Auto makers are required to begin the process of a recall by notifying the NHTSA within 5 days of when they know or should have known about a defect. Failing to notify the NHTSA can cause the agency to be subject to fines for each day they failed to notify the agency.

In the Hyundai recall, the automaker identified a similar defective airbag controller from the same supplier, ZF-TRW, over three months ago.

There is currently no repair for the recalled Kia airbag controllers, but Kia said it will notify vehicle owners once the automaker and suppler have decided on an appropriate fix.

Owners of affected vehicles can search the NHTSA website using their VIN to see if their vehicle is affected. They can also contact Kia customer service at 800-333-4542 for more information.

Written by: Martha Garcia

Health & Medical Research Writer

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.

Image Credit: Image via <a href="http://www.shutterstock.com/gallery-103978p1.html?cr=00&pl=edit-00">dcwcreations</a> / <a href="http://www.shutterstock.com/editorial?cr=00&pl=edit-00">Shutterstock.com</a>



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.
A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL.
Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation.